Management of carotid artery disease in the high-risk patient with emphasis on the SAPPHIRE study

被引:5
作者
Rajagopal V. [1 ]
Yadav J.S. [1 ]
机构
[1] CardioMEMS, Inc., Atlanta, GA 30308
关键词
Carotid Endarterectomy; Carotid Stenosis; Carotid Artery Stenting; National Surgical Quality Improvement Program; Carotid Artery Disease;
D O I
10.1007/s11886-007-0005-x
中图分类号
学科分类号
摘要
Ischemic stroke threatens public health dramatically, and demographic changes promise to continue this epidemic. Although medical advances in risk factor modification, hypertensive control, and antiplatelet therapy have mitigated morbidity and mortality of cerebrovascular disease somewhat, stroke still costs billions in healthcare dollars and reduces quality of life for many patients immeasurably. Carotid endarterectomy has been the standard for invasive management of carotid atherosclerosis, successfully reducing risk of stroke in asymptomatic and symptomatic patient. Despite this, many patients are at high risk for surgical intervention and have unacceptable outcomes. Fortunately, carotid artery stenting offers a less invasive and safer option for these patients. Given the recently published SAPPHIRE trial and other clinical trial data, it is likely that carotid artery stenting will supplant carotid endarterectomy for high-risk patients who require carotid revascularization. Copyright © 2007 by Current Medicine Group LLC.
引用
收藏
页码:20 / 24
页数:4
相关论文
共 25 条
[1]  
Heart Disease and Stroke Statistics - 2006 Update, (2006)
[2]  
Abelson P., Kennedy D., The obesity epidemic, Science, 304, (2004)
[3]  
Zimmer P., Alberti K.G., Shaw J., Global and societal implications of the diabetes epidemic, Nature, 414, pp. 782-787, (2001)
[4]  
Yadav J.S., Wholey M.H., Kuntz R.E., Et al., Protected carotid-artery stenting versus endarterectomy in high-risk patients, N Engl J Med, 351, pp. 1493-1501, (2004)
[5]  
Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis, N Engl J Med, 325, pp. 445-453, (1991)
[6]  
Randomised trial of endarterectomy for recently symptomatic carotid stenosis: Final results of the MRC European Carotid Surgery Trial (ECST), Lancet, 351, pp. 1379-1387, (1998)
[7]  
Mohammed N., Anand S.S., Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: Randomized controlled trial. MRC asymptomatic carotid surgery trial (ACST) collaborative group, Lancet, 363, pp. 1491-1502, (2004)
[8]  
Endarterectomy for asymptomatic carotid artery stenosis, JAMA, 273, pp. 1421-1428, (1995)
[9]  
Cebul R.D., Snow R.J., Pine R., Et al., Indications, outcomes, and provider volumes for carotid endarterectomy, JAMA, 279, pp. 1282-1287, (1998)
[10]  
Wennberg D.E., Lucas F.L., Birkmeyer J.D., Et al., Variation in carotid endarterectomy mortality in the Medicare population: Trial hospitals, volume, and patient characteristics, JAMA, 279, pp. 1278-1281, (1998)